PolarityTE is headquartered in Salt Lake City, Utah, the US.įor a complete picture of SkinTE’s drug-specific PTSR and LoA scores, buy the report here. Is PolarityTE (NASDAQ:PTE) a buy Compare the latest price, visualised quantitative ratios, annual reports, historical dividends, pricing and company. PolarityTE formerly Majesco Entertainment is focused on developing regenerative treatments and develop technology that will utilize a patient’s own tissue substrates for the regeneration of skin, bone, muscle, cartilage, fat, blood vessels and nerves. The therapeutic candidate is a personalized autologous regenerative therapy being developed based on minimally polarized functional unit (MPFU) technology. It is administered through topical route. SkinTE is under development for the treatment of diabetic foot ulcers, venous leg ulcers, other chronic wounds, acute or traumatic wounds and burns. Attributes of the drug, company and its clinical trials play a fundamental role in drug-specific PTSR and likelihood of approval. Duration : Period : Style : Dynamic Chart Latest news about PolarityTE, Inc.
(PTE) SA Transcripts 134.86K Follower s Q3. Corporate Main: 80 Investor Relations: 38 Public Relations: 80 Clinical Research: 80. PolarityTE, Inc.'s (PTE) CEO Richard Hague on Q3 2021 Results - Earnings Call Transcript Nov.
#POLARITY TE PDF#
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Equities PTEIQ US7310942070 Add to a list PDF Report Summary Quotes Charts News Ratings Calendar Company Financials Consensus Revisions Financials (USD) More Fundamentals Assessed data Chart PolarityTE, Inc. PolarityTE Headquarters: 1960 South 4250 West Salt Lake City, UT 84104.
0 kommentar(er)
